The Technical Analyst
Viveve Medical Inc [VIVE]
Exchange: NASDAQ Sector: Healthcare Industry: Medical Devices
Viveve Medical Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals
50.00% $0.0003
America/New_York / 19 apr 2024 @ 11:51
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 0.0032 mill |
| EPS: | -2.65 |
| P/E: | 0 |
| Earnings Date: | Apr 22, 2024 |
| SharesOutstanding: | 10.72 mill |
| Avg Daily Volume: | 0.0028 mill |
| RATING 2024-04-19 |
|---|
| A- |
| Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Strong Sell | |
| DE: | Strong Buy | |
| P/E: | Neutral | |
| Price To Book: | Strong Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 2/21 | 3/21 | 4/21 | 1/22 | 2/22 | 3/22 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE 0 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| N/A |
| Company: PE 0 | industry: PE 222.16 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ -0.0007 - 0.0013 ( +/- 333.33%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2023-01-03 | Basta Steven L | Buy | 72 000 | Restricted Stock Unit |
| 2023-01-03 | Durbin Scott | Buy | 360 000 | Restricted Stock Unit |
| 2023-01-03 | Jorn Debora | Buy | 36 000 | Restricted Stock Unit |
| 2023-01-03 | Morris Arlene | Buy | 36 000 | Restricted Stock Unit |
| 2023-01-03 | Presnell Sharon Collins | Buy | 36 000 | Restricted Stock Unit |
| INSIDER POWER |
|---|
| 100.00 |
| Last 95 transactions |
| Buy: 10 454 912 | Sell: 347 991 |
Forecast:
13:31 - $0
Live Trading Signals (every 1 min)
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 |
| Volume Signals | |
|---|---|
| Price | $0.0003 (50.00% ) |
| Volume | 0.0001 mill |
| Avg. Vol. | 0.0028 mill |
| % of Avg. Vol | 5.21 % |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For VIVE
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
VIVE
Viveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The company offers Viveve System comprises of the radiofrequency generator, reusable handpiece, and treatment tip, as well as cryogen canister and other consumable components. It markets its products through sales employees and distributors in the United States, Canada, the Asia Pacific, Europe, the Middle East, Latin America, and internationally. Viveve Medical, Inc. was founded in 2005 and is headquartered in Englewood, Colorado.
Last 10 Buy Signals
Latest Press Releases
2022-10-27 08:28:00 - Press Release
Viveve To Report Third Quarter 2022 Financial Results And Provide Corporate Update On November 10, 2022
Englewood, co / accesswire / october 27, 2022 / viveve medical, inc. (nasdaq:vive), a medical technology company focused on women's health and the treatment of stress urinary incontinence (sui), today announced that it will report its third quarter 2022 financial results and provide a corporate update after the close of the u.s. financial markets on thursday, november 10, 2022. the company will hold a conference call and webcast at 5:00 pm et the same day.
2022-07-28 16:28:00 - Press Release
Viveve To Report Second Quarter 2022 Financial Results And Provide Corporate Update On August 11, 2022
Englewood, co / accesswire / july 28, 2022 / viveve medical, inc. (nasdaq:vive), a medical technology company focused on women's health and the treatment of stress urinary incontinence (sui), today announced that it will report its second quarter 2022 financial results and provide a corporate update after the close of the u.s. financial markets on thursday, august 11, 2022. the company will hold a conference call and webcast at 5:00 pm et the same day.
2022-05-17 16:28:00 - Press Release
Viveve To Participate In H.c. Wainwright Global Investment Conference
Englewood, co / accesswire / may 17, 2022 / viveve medical, inc. (nasdaq:vive), a medical technology company focused on women's health, today announced that scott durbin, chief executive officer, will participate in the h.c. wainwright global investment conference, may 23 - 26, 2022.
2022-04-28 08:28:00 - Press Release
Viveve To Report First Quarter 2022 Financial Results And Provide Corporate Update On May 12, 2022
Englewood, co / accesswire / april 28, 2022 / viveve medical, inc. (nasdaq:vive), a medical technology company focused on women's intimate health, today announced that it will report its first quarter 2022 financial results and provide a corporate update after the close of the u.s. financial markets on thursday, may 12, 2022. the company will hold a conference call and webcast at 5:00 pm et the same day.
2021-11-02 08:28:00 - Press Release
Viveve To Host Conference Call On November 11, 2021 To Report Third Quarter Financial Results And Provide Corporate Update
Englewood, co / accesswire / november 2, 2021 / viveve medical, inc. (nasdaq:vive), a medical technology company focused on women's intimate health, today announced that it will report its third quarter 2021 financial results and provide a corporate update after the close of the u.s. financial markets on thursday, november 11, 2021. the company will hold a conference call and webcast at 5:00 pm et the same day.
Latest News
2023-01-17 08:43:42 - InvestorPlace
Why Is Viveve Medical (VIVE) Stock Down 69% Today?
Viveve Medical (NASDAQ: VIVE ) stock is falling hard on Tuesday after releasing results from the company's latest clinical trial. That trial covers the use of the Viveve treatment for women suffering from stress urinary incontinence.
2022-11-10 21:25:04 - Seeking Alpha
Viveve Medical, Inc. (VIVE) Q3 2022 Earnings Call Transcript
Viveve Medical, Inc. (NASDAQ:VIVE ) Q3 2022 Results Conference Call November 10, 2022 5:00 PM ET Company Participants Jeannie Swindle - Senior Director, Corporate Communications Scott Durbin - CEO Jim Robbins - SVP, Finance and Administration Operator Good afternoon. Welcome to the Viveve Third Quarter 2022 Financial Results and Corporate Update Conference Call.
2022-10-27 08:28:00 - Accesswire
Viveve to Report Third Quarter 2022 Financial Results and Provide Corporate Update on November 10, 2022
ENGLEWOOD, CO / ACCESSWIRE / October 27, 2022 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's health and the treatment of stress urinary incontinence (SUI), today announced that it will report its third quarter 2022 financial results and provide a corporate update after the close of the U.S. financial markets on Thursday, November 10, 2022. The Company will hold a conference call and webcast at 5:00 PM ET the same day.
2022-08-11 18:38:04 - Seeking Alpha
Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q2 2022 Results - Earnings Call Transcript
Viveve Medical, Inc. (NASDAQ:VIVE ) Q2 2022 Earnings Conference Call August 11, 2022 5:00 PM ET Company Participants Jeannie Swindle - Senior Director, Corporate Communications Jim Robbins - SVP, Finance and Administration Scott Durbin - CEO Conference Call Participants Operator Good afternoon, and welcome to the Viveve Second Quarter 2022 Financial Results and Corporate Update Conference Call. [Operator Instructions] Please note, this event is being recorded.
2022-07-28 16:28:00 - Accesswire
Viveve to Report Second Quarter 2022 Financial Results and Provide Corporate Update on August 11, 2022
ENGLEWOOD, CO / ACCESSWIRE / July 28, 2022 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's health and the treatment of stress urinary incontinence (SUI), today announced that it will report its second quarter 2022 financial results and provide a corporate update after the close of the U.S. financial markets on Thursday, August 11, 2022. The Company will hold a conference call and webcast at 5:00 PM ET the same day.
2022-05-17 16:28:00 - Accesswire
Viveve to Participate in H.C. Wainwright Global Investment Conference
ENGLEWOOD, CO / ACCESSWIRE / May 17, 2022 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's health, today announced that Scott Durbin, chief executive officer, will participate in the H.C. Wainwright Global Investment Conference, May 23 - 26, 2022.
2022-05-12 21:06:01 - Seeking Alpha
Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q1 2022 Results - Earnings Call Transcript
Viveve Medical, Inc. (NASDAQ:VIVE ) Q1 2022 Earnings Conference Call May 12, 2022 5:00 PM ET Company Participants Jeannie Swindle - Senior Director, Corporate Communications Jim Robbins - Senior Vice President, Finance and Administration Scott Durbin - Chief Executive Officer Conference Call Participants Operator Good afternoon, and welcome to the Viveve First Quarter 2022 Financial Results and Corporate Update Conference Call. All participants will be in a listen-only mode.
2022-04-28 08:28:00 - Accesswire
Viveve to Report First Quarter 2022 Financial Results and Provide Corporate Update on May 12, 2022
ENGLEWOOD, CO / ACCESSWIRE / April 28, 2022 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that it will report its first quarter 2022 financial results and provide a corporate update after the close of the U.S. financial markets on Thursday, May 12, 2022. The Company will hold a conference call and webcast at 5:00 PM ET the same day.
2022-03-17 19:44:05 - Seeking Alpha
Viveve Medical Inc. (VIVE) CEO Scott Durbin on Q4 2021 Results - Earnings Call Transcript
Viveve Medical Inc. (VIVE) CEO Scott Durbin on Q4 2021 Results - Earnings Call Transcript
2021-11-11 20:45:27 - Seeking Alpha
Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q3 2021 Results - Earnings Call Transcript
Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q3 2021 Results - Earnings Call Transcript